{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:00:08Z","timestamp":1793350808579,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018279","name":"HAL Allergy","doi-asserted-by":"publisher","award":["PCT\/US2021\/065576"],"award-info":[{"award-number":["PCT\/US2021\/065576"]}],"id":[{"id":"10.13039\/100018279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018279","name":"HAL Allergy","doi-asserted-by":"publisher","award":["PCT\/US2015\/054943"],"award-info":[{"award-number":["PCT\/US2015\/054943"]}],"id":[{"id":"10.13039\/100018279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019C00035"],"award-info":[{"award-number":["75N93019C00035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jaci.2022.05.002","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T04:25:00Z","timestamp":1652415900000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["The unfulfilled potential of mucosal immunization"],"prefix":"10.1016","volume":"150","author":[{"suffix":"Jr.","given":"James R.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.","family":"O\u2019Konek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.05.002_bib1","doi-asserted-by":"crossref","first-page":"809244","DOI":"10.3389\/fimmu.2021.809244","article-title":"SARS-CoV-2 variants, vaccines, and host immunity","volume":"12","author":"Mistry","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib2","doi-asserted-by":"crossref","first-page":"103841","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: from bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaci.2022.05.002_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.imlet.2019.10.013","article-title":"Mucosal vaccines: strategies and challenges","volume":"217","author":"Li","year":"2020","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2022.05.002_bib4","doi-asserted-by":"crossref","first-page":"121180","DOI":"10.1016\/j.ijpharm.2021.121180","article-title":"Intranasal vaccine: factors to consider in research and development","volume":"609","author":"Xu","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jaci.2022.05.002_bib5","doi-asserted-by":"crossref","first-page":"781280","DOI":"10.3389\/fimmu.2021.781280","article-title":"An intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection","volume":"12","author":"van der Ley","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41577-021-00662-4","article-title":"SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact","volume":"22","author":"Lipsitch","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib7","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.4110\/in.2020.20.e44","article-title":"Recent insights into cellular crosstalk in respiratory and gastrointestinal mucosal immune systems","volume":"20","author":"Kim","year":"2020","journal-title":"Immune Netw"},{"key":"10.1016\/j.jaci.2022.05.002_bib8","doi-asserted-by":"crossref","first-page":"ltab017","DOI":"10.1093\/immadv\/ltab017","article-title":"Oral tolerance as antigen-specific immunotherapy","volume":"1","author":"Pinheiro-Rosa","year":"2021","journal-title":"Immunother Adv"},{"key":"10.1016\/j.jaci.2022.05.002_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/intimm\/dxu063","article-title":"Challenges in mucosal vaccines for the control of infectious diseases","volume":"26","author":"Azegami","year":"2014","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1051\/vetres:2006012","article-title":"Mucosal delivery of vaccines in domestic animals","volume":"37","author":"Gerdts","year":"2006","journal-title":"Vet Res"},{"key":"10.1016\/j.jaci.2022.05.002_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13285","article-title":"Mucosal vaccines and technology","volume":"196","author":"Miquel-Clop\u00e9s","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.jaci.2022.05.002_bib13","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41590-021-01028-7","article-title":"Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection","volume":"22","author":"Smith","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3904\/kjim.2020.203","article-title":"Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms\/signs","volume":"35","author":"Park","year":"2020","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jaci.2022.05.002_bib15","doi-asserted-by":"crossref","unstructured":"Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med [published online ahead of print May 25, 2022]. doi: https:\/\/doi.org\/10.1038\/s41591-022-01840-0.","DOI":"10.1038\/s41591-022-01840-0"},{"key":"10.1016\/j.jaci.2022.05.002_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncpgasthep1264","article-title":"Mechanisms of infectious diarrhea","volume":"5","author":"Navaneethan","year":"2008","journal-title":"Nat Rev Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2022.05.002_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.femsre.2004.07.002","article-title":"Enteropathogenic Escherichia coli: unravelling pathogenesis","volume":"29","author":"Chen","year":"2005","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jaci.2022.05.002_bib18","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1053\/j.gastro.2009.02.076","article-title":"Rotaviruses: from pathogenesis to vaccination","volume":"136","author":"Greenberg","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.05.002_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1057","article-title":"Anatomical basis of tolerance and immunity to intestinal antigens","volume":"3","author":"Mowat","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib20","doi-asserted-by":"crossref","first-page":"154866","DOI":"10.1016\/j.cyto.2019.154866","article-title":"Co-expression of interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice","volume":"126","author":"Nemattalab","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2022.05.002_bib21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.15585\/mmwr.mm7031e2","article-title":"Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings\u2014Barnstable County, Massachusetts, July 2021","volume":"70","author":"Brown","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2022.05.002_bib22","doi-asserted-by":"crossref","first-page":"701285","DOI":"10.3389\/fimmu.2021.701285","article-title":"Mucosal immunization against pertussis: lessons from the past and perspectives","volume":"12","author":"Dubois","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.05.002_bib24","first-page":"287","article-title":"Clostridium difficile infection","volume":"373","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.05.002_bib25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nri3887","article-title":"The nature of immune responses to urinary tract infections","volume":"15","author":"Abraham","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines\u2014fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1573395514666180605092054","article-title":"Mucosal vaccine approaches for prevention of HIV and SIV transmission","volume":"15","author":"Kozlowski","year":"2019","journal-title":"Curr Immunol Rev"},{"key":"10.1016\/j.jaci.2022.05.002_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40263-018-0518-4","article-title":"Beyond the magic bullet: current progress of therapeutic vaccination in multiple sclerosis","volume":"32","author":"Willekens","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaci.2022.05.002_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s40618-017-0641-y","article-title":"Immunotherapy for type 1 diabetes","volume":"40","author":"Frumento","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jaci.2022.05.002_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/cea.13824","article-title":"Mechanisms of oral immunotherapy","volume":"51","author":"Barshow","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2022.05.002_bib31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/BF02976990","article-title":"Airway mucus: its components and function","volume":"25","author":"Lillehoj","year":"2002","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jaci.2022.05.002_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13233-019-7042-3","article-title":"Efficient mucosal immunization by mucoadhesive and pH-sensitive polymeric vaccine delivery system","volume":"27","author":"Xing","year":"2019","journal-title":"Macromol Res"},{"key":"10.1016\/j.jaci.2022.05.002_bib33","doi-asserted-by":"crossref","first-page":"a029314","DOI":"10.1101\/cshperspect.a029314","article-title":"Cell biology of tight junction barrier regulation and mucosal disease","volume":"10","author":"Buckley","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jaci.2022.05.002_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.cellbio.16.1.301","article-title":"Epithelial M cells: differentiation and function","volume":"16","author":"Kraehenbuhl","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jaci.2022.05.002_bib36","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"361","author":"Monto","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.05.002_bib37","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.4110\/in.2021.21.e6","article-title":"Adenovirus vectors: excellent tools for vaccine development","volume":"21","author":"Chang","year":"2021","journal-title":"Immune Netw"},{"key":"10.1016\/j.jaci.2022.05.002_bib38","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mi.2013.30","article-title":"Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium","volume":"6","author":"Mabbott","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer\u2019s-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","article-title":"Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells","volume":"36","author":"Tartey","year":"2017","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib42","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1002\/jmv.27265","article-title":"Viral proteins recognized by different TLRs","volume":"93","author":"Zhou","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaci.2022.05.002_bib43","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1172\/JCI60659","article-title":"Cross-presenting CD103+ dendritic cells are protected from influenza virus infection","volume":"122","author":"Helft","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.05.002_bib44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.f.208","article-title":"Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking","volume":"9","author":"Sigmundsdottir","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature01726","article-title":"Selective imprinting of gut-homing T cells by Peyer\u2019s patch dendritic cells","volume":"424","author":"Mora","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.05.002_bib46","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/eji.200838932","article-title":"Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products","volume":"39","author":"Allard","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib47","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3390\/ijms20092159","article-title":"Dendritic cell-mediated Th2 immunity and immune disorders","volume":"20","author":"Kumar","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2022.05.002_bib48","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1084\/jem.20080414","article-title":"Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans","volume":"205","author":"Jaensson","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.05.002_bib49","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.05.002_bib50","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3389\/fimmu.2019.01499","article-title":"M cells: intelligent engineering of mucosal immune surveillance","volume":"10","author":"Dillon","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib51","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.05.002_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41385-021-00467-7","article-title":"Human mucosal tissue-resident memory T cells in health and disease","volume":"15","author":"Lange","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib53","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3389\/fimmu.2018.01214","article-title":"Niches for the long-term maintenance of tissue-resident memory T cells","volume":"9","author":"Takamura","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fimmu.2020.00116","article-title":"Immunoregulatory sensory circuits in group 3 innate lymphoid cell (ILC3) function and tissue homeostasis","volume":"11","author":"Domingues","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00018-017-2693-8","article-title":"Mouse models for human intestinal microbiota research: a critical evaluation","volume":"75","author":"Hugenholtz","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2022.05.002_bib56","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jama.1957.62980110008008","article-title":"Properties and behavior of orally administered attenuated poliovirus vaccine","volume":"164","author":"Sabin","year":"1957","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jaci.2022.05.002_bib57","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/vaccines9090998","article-title":"Safety and efficacy of spray intranasal live attenuated influenza vaccine: systematic review and meta-analysis","volume":"9","author":"Perego","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jaci.2022.05.002_bib58","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14760584.2019.1675520","article-title":"Vaccines against human respiratory syncytial virus in clinical trials, where are we now?","volume":"18","author":"Rossey","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jaci.2022.05.002_bib61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jpids\/pix006","article-title":"Evaluation of a live attenuated human metapneumovirus vaccine in adults and children","volume":"7","author":"Karron","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.jaci.2022.05.002_bib62","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/321905","article-title":"Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication","volume":"33","author":"C\u00e1ceres","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2022.05.002_bib63","article-title":"Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.05.002_bib71","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.xphs.2020.11.015","article-title":"The science is there: key considerations for stabilizing viral vector-based Covid-19 vaccines","volume":"110","author":"Crommelin","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jaci.2022.05.002_bib72","doi-asserted-by":"crossref","unstructured":"Samaranayake LP, Seneviratne CJ, Fakhruddin KS. Coronavirus disease 2019 (COVID-19) vaccines: a concise review [published online ahead of print May 15, 2021]. Oral Dis. https:\/\/doi.org\/10.1111\/odi.13916.","DOI":"10.1111\/odi.13916"},{"key":"10.1016\/j.jaci.2022.05.002_bib73","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1038\/emm.2013.165","article-title":"Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines","volume":"46","author":"Kim","year":"2014","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jaci.2022.05.002_bib74","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/bit.25159","article-title":"Bioengineering virus-like particles as vaccines","volume":"111","author":"Lua","year":"2014","journal-title":"Biotechnol Bioeng"},{"issue":"4-S","key":"10.1016\/j.jaci.2022.05.002_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.22270\/jddt.v11i4-S.4942","article-title":"A review on modern use of intranasal vaccination in the treatment of SARS-COV-2","volume":"11","author":"Shah","year":"2021","journal-title":"JDDT"},{"key":"10.1016\/j.jaci.2022.05.002_bib76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00197-1","article-title":"Chitosan for mucosal vaccination","volume":"52","author":"van der Lubben","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jaci.2022.05.002_bib77","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijbiomac.2020.03.065","article-title":"Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): the potential immune adjuvants and nano carriers","volume":"154","author":"Zhao","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jaci.2022.05.002_bib78","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4161\/hv.27449","article-title":"Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines","volume":"10","author":"Smith","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jaci.2022.05.002_bib79","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/infdis\/jiz540","article-title":"Production and clinical evaluation of Norwalk GI.1 virus Lot 001-09NV in norovirus vaccine development","volume":"221","author":"Mateo","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2022.05.002_bib80","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/08982104.2019.1668010","article-title":"A comprehensive review on recent preparation techniques of liposomes","volume":"30","author":"Has","year":"2020","journal-title":"J Liposome Res"},{"key":"10.1016\/j.jaci.2022.05.002_bib81","doi-asserted-by":"crossref","first-page":"5482087","DOI":"10.1155\/2016\/5482087","article-title":"Mucosal vaccine development based on liposome technology","volume":"2016","author":"Bernasconi","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2022.05.002_bib83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2011.10.094","article-title":"Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens","volume":"30","author":"Stanberry","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2022.05.002_bib85","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00508-017-1285-9","article-title":"Review of cancer treatment with immune checkpoint inhibitors: current concepts, expectations, limitations and pitfalls","volume":"130","author":"Thallinger","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jaci.2022.05.002_bib86","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd4476","article-title":"The immune checkpoint inhibitors: where are we now?","volume":"13","author":"Webster","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2022.05.002_bib87","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14737140.2020.1816173","article-title":"Promising predictors of checkpoint inhibitor response in NSCLC","volume":"20","author":"Alex","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jaci.2022.05.002_bib88","doi-asserted-by":"crossref","first-page":"643255","DOI":"10.3389\/fimmu.2021.643255","article-title":"Immunomodulation by the commensal microbiome during immune-targeted interventions: focus on cancer immune checkpoint inhibitor therapy and vaccination","volume":"12","author":"Reens","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coph.2018.03.015","article-title":"ADP-ribosylating enterotoxins as vaccine adjuvants","volume":"41","author":"Lycke","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jaci.2022.05.002_bib90","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1128\/JVI.02035-08","article-title":"Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination","volume":"83","author":"Quan","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2022.05.002_bib91","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1473-3099(19)30571-7","article-title":"Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1\/2 trial","volume":"20","author":"Qadri","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaci.2022.05.002_bib92","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.05.002_bib93","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41385-020-0334-2","article-title":"A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection","volume":"14","author":"Bernasconi","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib94","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41598-018-20632-6","article-title":"Oral delivery of siRNA lipid nanoparticles: fate in the GI tract","volume":"8","author":"Ball","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2022.05.002_bib95","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00841-21","article-title":"Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza virus antigen that is sufficient to mediate protection from influenza virus challenge","volume":"95","author":"Nelson","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2022.05.002_bib96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13567-020-00762-4","article-title":"Intranasally administered protein coated chitosan nanoparticles encapsulating influenza H9N2 HA2 and M2e mRNA molecules elicit protective immunity against avian influenza viruses in chickens","volume":"51","author":"Hajam","year":"2020","journal-title":"Vet Res"},{"key":"10.1016\/j.jaci.2022.05.002_bib97","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","article-title":"The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial","volume":"390","author":"Rouphael","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.05.002_bib98","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coi.2017.07.010","article-title":"Towards an evidence based approach for the development of adjuvanted vaccines","volume":"47","author":"O\u2019Hagan","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2022.05.002_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03537-20","article-title":"Prime-pull immunization with a bivalent M-protein and spy-CEP peptide vaccine adjuvanted with CAF\u00ae01 liposomes induces both mucosal and peripheral protection from covR\/S mutant Streptococcus pyogenes","volume":"12","author":"Ozberk","year":"2021","journal-title":"mBio"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922006285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922006285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:04:04Z","timestamp":1777475044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922006285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0091674922006285"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.05.002","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The unfulfilled potential of mucosal immunization","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}